Lista de obras - Giuseppe Cabibbo - Dominio Público Uruguay

A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.

artículo científico publicado en 2017

Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.

artículo científico publicado en 2016

Assessment of treatment response in hepatocellular carcinoma: a review of the literature.

artículo científico

Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.

artículo científico publicado en 2013

Causes of and prevention strategies for hepatocellular carcinoma.

artículo científico

Computed tomography of bowel obstruction: tricks of the trade

artículo científico

Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma.

artículo científico publicado en 2010

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2014

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

artículo científico publicado en 2013

Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.

artículo científico publicado en 2016

Curative therapies for hepatocellular carcinoma: an update and perspectives

artículo científico publicado en 2015

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

artículo científico publicado en 2014

Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma

artículo científico publicado en 2016

Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing

artículo científico publicado en 2016

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

scientific article published on 06 April 2019

EASL HCC summit: liver cancer management

artículo científico publicado en 2014

Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension

artículo científico publicado en 2016

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.

artículo científico publicado en 2014

European Association for the Study of the Liver Hepatocellular Carcinoma summit 2014: old questions, new (or few) answers?

artículo científico publicado en 2014

Faculty of 1000 evaluation for Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

article

First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials

artículo científico publicado en 2021

Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?

artículo científico publicado en 2014

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.

artículo científico publicado en 2017

Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report

artículo científico publicado en 2013

Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results

artículo científico publicado en 2013

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

artículo científico publicado en 2016

Hyperferritinemia is a risk factor for steatosis in chronic liver disease.

artículo científico publicado en 2009

Imaging appearance of treated hepatocellular carcinoma

artículo científico

Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device—Initial observations

artículo científico publicado en 2011

Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study

artículo científico

Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?

artículo científico publicado en 2013

Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease

artículo científico publicado en 2008

MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.

artículo científico publicado en 2016

Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid

artículo científico publicado en 2016

Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease.

artículo científico publicado en 2008

Metabolic disorders across hepatocellular carcinoma in Italy

article

Minor hepatic resection using heat coagulative necrosis

artículo científico publicado en 2009

Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.

artículo científico

Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysis

scientific article published on 20 May 2019

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis

artículo científico publicado en 2020

Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials

artículo científico publicado en 2019

Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice

artículo científico publicado en 2017

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2014

Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation

artículo científico publicado en 2011

Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib.

artículo científico publicado en 2015

Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist.

artículo científico publicado en 2013

Prognostic scores for hepatocellular carcinoma: none is the winner

artículo científico publicado en 2009

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma

artículo científico publicado en 2020

Recurrence of hepatocellular carcinoma after liver transplantation: an update

artículo científico

Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma

artículo científico publicado en 2015

Reply

Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis

artículo científico publicado en 2009

Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.

artículo científico publicado en 2013

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals

artículo científico publicado en 2022

Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure

artículo científico publicado en 2015

Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: A prospective study

artículo científico publicado en 2008

Should cirrhosis change our attitude towards treating non-hepatic cancer?

artículo científico publicado en 2011

Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice.

artículo científico

Staging systems of hepatocellular carcinoma: a review of literature

artículo científico

Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2014

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.

artículo científico publicado en 2014

Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis

artículo científico publicado en 2015

Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population

artículo científico publicado en 2016

Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological response

artículo científico publicado en 2013

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

artículo científico publicado en 2008

The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2.

artículo científico publicado en 2016

The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.

artículo científico publicado en 2016

The changing scenario of hepatocellular carcinoma in Italy: an update

artículo científico publicado en 2020

The cheating liver: imaging of focal steatosis and fatty sparing.

artículo científico publicado en 2016

The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study

artículo científico publicado en 2019

The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.

artículo científico publicado en 2007

Transarterial chemoembolization and sorafenib in hepatocellular carcinoma

artículo científico

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?

artículo científico publicado en 2015

Treatment of hepatitis C: critical appraisal of the evidence.

artículo científico publicado en 2005

Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study

artículo científico publicado en 2005

Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?

artículo científico publicado en 2015

Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.

artículo científico publicado en 2015

Lista de obras de Giuseppe Cabibbo

A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.

Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.

Assessment of treatment response in hepatocellular carcinoma: a review of the literature.

Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.

Causes of and prevention strategies for hepatocellular carcinoma.

Computed tomography of bowel obstruction: tricks of the trade

Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma.

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.

Curative therapies for hepatocellular carcinoma: an update and perspectives

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma

Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

EASL HCC summit: liver cancer management

Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.

European Association for the Study of the Liver Hepatocellular Carcinoma summit 2014: old questions, new (or few) answers?

Faculty of 1000 evaluation for Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials

Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.

Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report

Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

Hyperferritinemia is a risk factor for steatosis in chronic liver disease.

Imaging appearance of treated hepatocellular carcinoma

Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device—Initial observations

Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study

Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?

Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease

MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.

Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid

Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease.

Metabolic disorders across hepatocellular carcinoma in Italy

Minor hepatic resection using heat coagulative necrosis

Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.

Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysis

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis

Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials

Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation

Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib.

Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist.

Prognostic scores for hepatocellular carcinoma: none is the winner

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma

Recurrence of hepatocellular carcinoma after liver transplantation: an update

Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma

Reply

Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis

Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals

Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure

Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: A prospective study

Should cirrhosis change our attitude towards treating non-hepatic cancer?

Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice.

Staging systems of hepatocellular carcinoma: a review of literature

Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.

Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis

Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population

Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological response

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2.

The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.

The changing scenario of hepatocellular carcinoma in Italy: an update

The cheating liver: imaging of focal steatosis and fatty sparing.

The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study

The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.

Transarterial chemoembolization and sorafenib in hepatocellular carcinoma

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?

Treatment of hepatitis C: critical appraisal of the evidence.

Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study

Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?

Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.